| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920362 | Radiotherapy and Oncology | 2005 | 4 Pages |
Abstract
Concurrent vinablastine-based radiochemotherapy was evaluated in 84 bladder-cancer patients. It was effective in more than half: tumour-specific survival (51% 9-year), local control rate (55% 9-year). The drawback was the impaired function of the bladder (9-year prevalence SOMA G3-4 symptoms: 66%), indicating the need for treatment aimed at reducing chronic morbidity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Borut Kragelj, Lijana Zaletel-Kragelj, Boris Sedmak, Tanja Äufer, Jožica Äervek,